Abstract:the number of patients achieving major molecular and complete cytogenetic responses. Fewer patients treated with nilotinib progressed to advance or blast phase than with imatinib. The objective of this analysis was to assess, from a HK societal perspective, the cost and quality-adjusted-life-years (QALYs) of imatinib versus nilotinib in newly-diagnosed Phϩ CML-CP. METHODS: A literature-based Markov model was developed to estimate the lifetime QALYs and costs of typical 47 yearold CML-CP patients initiating fir… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.